| 000 | 01608 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511152722.0 | ||
| 264 | 0 | _c19770125 | |
| 008 | 197701s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1093/infdis/135.supplement_2.s394 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathias, R G | |
| 245 | 0 | 0 |
_aClinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cNov 1976 |
||
| 300 |
_aS394-401 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmikacin _xadverse effects |
| 650 | 0 | 4 |
_aAminoglycosides _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKanamycin _xanalogs & derivatives |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 |
_aSepsis _xdrug therapy |
| 650 | 0 | 4 |
_aUrinary Tract Infections _xdrug therapy |
| 700 | 1 | _aRonald, A R | |
| 700 | 1 | _aGurwith, M J | |
| 700 | 1 | _aMcCullough, D W | |
| 700 | 1 | _aStiver, H G | |
| 700 | 1 | _aBerger, J | |
| 700 | 1 | _aCates, C Y | |
| 700 | 1 | _aFox, L M | |
| 700 | 1 | _aLank, B A | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 134 SUPPL _gp. S394-401 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/135.supplement_2.s394 _zAvailable from publisher's website |
| 999 |
_c833315 _d833315 |
||